Jim Fessenden, UMass Medical School Communications

A pair of studies in the journal Nature, one by Jeremy Luban, MD, and colleagues in Italy and Switzerland, and the other by Heinrich Gottlinger, MD, PhD, and colleagues; have identified genes that disable HIV-1, suggesting a promising new strategy for battling the virus that causes AIDS. The studies, published online Sept. 30, show that…

aidsmeds

In addition to possibly being a component of the HIV reservoir, fat tissue may also be a source of harmful chronic inflammation among those living with the virus. Publishing their findings in PLOS Pathogens, researchers studied adipose (fat) tissue in both macaque monkeys infected with SIV, HIV’s simian cousin, as well as HIV-positive humans who…

A Royal Perth Hospital immunologist investigating the possibility of using an antibody to trigger natural immune responses to fight HIV is one of 131 researchers benefitting from about $6 million of State Government funding. Announcing round 18 of the annual Medical and Health Research Infrastructure Fund (MHRIF) grants, Health Minister Dr Kim Hames said Professor…

aidsmeds

Sangamo Biosciences’ efforts to develop genetic therapies for HIV have had some early success, with two of three participants in one cohort maintaining control of the virus for an extended period during which they were not taking standard antiretroviral (ARV) treatment. The biotech company is conducting a Phase I/II study, known as SB-728-1101, of its…

By Jeffrey Laurence, M.D., and Rowena Johnston, Ph.D

The remarkable stability of the reservoir of latent HIV in a patient on effective antiretroviral therapy (ART) is measured in many decades. But the mechanisms by which this is achieved are under debate. Two possibilities are: 1) the viral reservoir may maintain its size by infected cells continuing to produce virus that infects other cells…

Nicola McCaskill and Sasha Petrova

Researchers have found a promising way of kicking the AIDS virus out of its hiding place in infected cells, potentially removing the main obstacle to curing HIV. While antiretroviral treatment successfully suppresses HIV replication in an infected person, it can’t completely remove the virus. This is due to the virus’ ability to integrate itself into…

Supported by

Supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI096109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About NAPWHA

Founded in 1989, The National Association of People with HIV Australia (NAPWHA) is Australia’s peak non-government organisation representing community-based groups of people living with HIV (PLHIV).